Leon A. Adams

2003–2025 年に発表

116
論文数
36,160
被引用数
77
h 指数
108
i10 指数

被引用数

Leon A. Adams の年別被引用数1991 年: 被引用 1 件1997 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 13 件2005 年: 被引用 47 件2006 年: 被引用 135 件2007 年: 被引用 134 件2008 年: 被引用 238 件2009 年: 被引用 216 件2010 年: 被引用 252 件2011 年: 被引用 242 件2012 年: 被引用 264 件2013 年: 被引用 283 件2014 年: 被引用 302 件2015 年: 被引用 324 件2016 年: 被引用 347 件2017 年: 被引用 377 件2018 年: 被引用 313 件2019 年: 被引用 1,221 件2020 年: 被引用 1,565 件2021 年: 被引用 1,859 件2022 年: 被引用 1,731 件2023 年: 被引用 1,417 件2024 年: 被引用 2,068 件2025 年: 被引用 1,155 件2026 年: 被引用 37 件1992〜1996 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,187 件、この内訳の 18.1%中国: 引用元論文 2,568 件、この内訳の 14.6%イタリア: 引用元論文 1,133 件、この内訳の 6.4%イギリス: 引用元論文 1,025 件、この内訳の 5.8%日本: 引用元論文 632 件、この内訳の 3.6%ドイツ: 引用元論文 623 件、この内訳の 3.6%韓国: 引用元論文 622 件、この内訳の 3.5%オーストラリア: 引用元論文 535 件、この内訳の 3.1%スペイン: 引用元論文 527 件、この内訳の 3%フランス: 引用元論文 512 件、この内訳の 2.9%インド: 引用元論文 340 件、この内訳の 1.9%カナダ: 引用元論文 339 件、この内訳の 1.9%
0%18.1%その他 31.6%

分野

  • Medicine84.5%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Nursing2.9%
  • Immunology and Microbiology1%
  • Environmental Science0.6%
  • Agricultural and Biological Sciences0.5%
  • その他2%

トピック

  • Liver Disease Diagnosis and Treatment26.5%
  • Liver Disease and Transplantation6.9%
  • Diet, Metabolism, and Disease6.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.4%
  • Alcohol Consumption and Health Effects3.5%
  • Liver Diseases and Immunity3%
  • その他49.3%

共著者

全論文

検索で開く
  1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vlad Ratziu, Jacob George - Journal of Hepatology 2020 被引用: 4,410

  2. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , , , , - Gastroenterology 2015 被引用: 2,950

  3. The NAFLD fibrosis score

    著者: , , , , , , , , , , , , , , , , - Hepatology 2007 被引用: 3,200

  4. Advancing the global public health agenda for NAFLD: a consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yusuf Yılmaz, Zobair M. Younossi, Shira Zelber‐Sagi, Fredrik Åberg, Leon A. Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Abdullatif Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramón Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourlière, Radan Brůha, Elisabetta Bugianesi, Patrizia Burra, Marı́a Buti, Christopher D. Byrne, José Luís Calleja, Patrizia Carrieri, Flloyd Carter, Marlén Ivón Castellanos Fernández, Gabriela Castillo-Lopez, Graciela Castro‐Narro, Henry Lik‐Yuen Chan, Wah‐Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen E. Corey, Antonio Craxı̀, Donna R. Cryer, Anuradha Supun Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Lédinghen, Stefano DelPrato, Sandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Gamal Esmat, Jian‐Gao Fan, Nathalie J. Farpour‐Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino Alvani Gani, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon‐Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch ほか 121 名 - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 736

  5. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , , , , , , , - Gastroenterology 2021 被引用: 573

  6. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , - Hepatology International 2020 被引用: 845

  7. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

    著者: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 544

  8. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

    著者: , , , - Gut 2017 被引用: 1,196

  9. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

    著者: , , , , , , , , , , , , , , , , - Gastroenterology 2018 被引用: 792

  10. Global burden of metabolic diseases, 1990–2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leon A. Adams, Said A. Al‐Busafi, Ala I. Sharara, Wah‐Kheong Chan, Syed Imran Abbas, Silvia Sookoian, Sombat Treeprasertsuk, Ponsiano Ocama, Khalid Alswat, Alice P.S. Kong, Karim Ataya, Michelle Ching Lim-Loo, Rodolfo J. Oviedo, Olivia Szepietowski, Yasser Fouad, Huijie Zhang, Tamer N Abdelbaki, Christos S. Katsouras, Arun Prasad, Omar Thaher, Arshad Ali, Gabriel A Molina, Ki‐Chul Sung, Qin‐Fen Chen, Cosmas Rinaldi Adithya Lesmana, Ming‐Hua Zheng - Metabolism 2024 被引用: 302

  11. Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

    著者: , , , , - Nature Reviews Gastroenterology & Hepatology 2018 被引用: 620

  12. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

    著者: , , , , , , - Gastroenterology 2005 被引用: 2,896

  13. Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2021 被引用: 246

  14. A global research priority agenda to advance public health responses to fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shiv Kumar Sarin, Marcelo Silva, C Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A. Alqahtani, Marco Arrese, Ramón Bataller, Thomas Berg, Paul Brennan, Patrizia Burra, Graciela Castro‐Narro, Helena Cortez‐Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven Francque, Hannes Hagström, Terry T.‐K. Huang, Dana Ivancovsky‐Wajcman, Achim Kautz, Christopher J. Kopka, Aleksander Krag, Veronica Miller, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C. Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Fredrik Åberg, Leon A. Adams, Khalid Al‐Naamani, Reda Albadawy, Zinaida Alexa, Michael Allison, Faisal Abdullatif Alnaser, Khalid Alswat, Mário Reis Álvares‐da‐Silva, Domenico Alvaro, Michele Alves‐Bezerra, Raúl J. Andrade, Quentin M. Anstee, Yaw Asante Awuku, Oidov Baatarkhuu, György Baffy, Shokhista Bakieva, Meena B. Bansal, Robert Barouki, Rachel L. Batterham ほか 241 名 - Journal of Hepatology 2023 被引用: 132

  15. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasser Fouad, Christos S. Mantzoros, Huijie Zhang, Nahúm Méndez‐Sánchez, Silvia Sookoian, Wah‐Kheong Chan, Sombat Treeprasertsuk, Leon A. Adams, Ponsiano Ocama, John Ryan, Nilanka Perera, Ala I. Sharara, Said A. Al‐Busafi, Christopher Opio, Manuel Garcia, Michelle Ching Lim-Loo, Elena Ruiz‐Úcar, Arun Prasad, Anna Casajoana, Tamer N. Abdelbaki, Ming‐Hua Zheng - EClinicalMedicine 2024 被引用: 191

  16. The Natural Course of Non-Alcoholic Fatty Liver Disease

    著者: , - International Journal of Molecular Sciences 2016 被引用: 626

  17. Advances in non-invasive assessment of hepatic fibrosis

    著者: , - Gut 2020 被引用: 326

  18. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2019 被引用: 322

  19. Lifestyle modification in NAFLD/NASH: Facts and figures

    著者: , - JHEP Reports 2019 被引用: 262

  20. Ad Libitum Mediterranean and Low‐Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial

    著者: , , , , , , , , , - Hepatology 2018 被引用: 221

  21. Geographical similarity and differences in the burden and genetic predisposition of NAFLD

    著者: , , , , , , , , - Hepatology 2022 被引用: 120

  22. ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2018 被引用: 257

  23. Extrahepatic complications of nonalcoholic fatty liver disease

    著者: , , , - Hepatology 2013 被引用: 605

  24. The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH

    著者: , - Hepatology 2019 被引用: 152